Consolidated Statement Of Cash Flows

D.Western Therapeutics Institute, Inc. - Filing #7721214

Concept 2018-01-01 to
2018-06-30
As at
2018-06-30
As at
2017-12-31
As at
2017-06-30
2017-01-01 to
2017-06-30
As at
2016-12-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-386,553,000 JPY
-1,345,848,000 JPY
Depreciation
24,552,000 JPY
17,090,000 JPY
Impairment losses
JPY
1,040,000,000 JPY
Interest expenses
3,153,000 JPY
2,226,000 JPY
Foreign exchange losses (gains)
267,000 JPY
10,166,000 JPY
Subtotal
-250,607,000 JPY
-416,452,000 JPY
Decrease (increase) in trade receivables
-1,767,000 JPY
-7,842,000 JPY
Income taxes paid
-1,438,000 JPY
-1,244,000 JPY
Net cash provided by (used in) operating activities
-255,164,000 JPY
-417,701,000 JPY
Other, net
76,660,000 JPY
-160,254,000 JPY
Interest paid
-3,171,000 JPY
-2,226,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-795,000 JPY
-2,618,000 JPY
Net cash provided by (used in) investing activities
-395,000 JPY
-1,043,322,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
JPY
582,000,000 JPY
Net cash provided by (used in) financing activities
JPY
1,406,969,000 JPY
Effect of exchange rate change on cash and cash equivalents
-21,000 JPY
-9,717,000 JPY
Net increase (decrease) in cash and cash equivalents
-255,581,000 JPY
-63,771,000 JPY
Cash and cash equivalents
1,877,095,000 JPY
2,132,677,000 JPY
2,228,163,000 JPY
2,291,934,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.